Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rigel Pharmaceuticals
Pharma
Lilly's Retevmo succeeds as adjuvant treatment in NSCLC
Lilly has reported a successful phase 3 trial of Retevmo in the adjuvant setting, showing improvement in event free survival in NSCLC patients.
Kevin Dunleavy
Feb 17, 2026 11:02am
'The Top Line': Alzheimer's developments, plus this week's headlines
Dec 9, 2022 6:00am
Rigel's nod for Rezlidhia sets up battle with Servier in AML
Dec 2, 2022 9:57am
Grifols opens plant, snags NICE nod for Tavlesse
Oct 19, 2022 10:15am
FDA denies Rigel's Tavalisse an early EUA in COVID-19
Aug 13, 2021 10:52am
Pfizer, Zogenix, Catalyst, Rigel raise prices to start July
Jul 1, 2021 10:16am
